These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
185 related articles for article (PubMed ID: 14697774)
41. Extrastriatal dopamine D2 and D3 receptors in early and advanced Parkinson's disease. Kaasinen V; Någren K; Hietala J; Oikonen V; Vilkman H; Farde L; Halldin C; Rinne JO Neurology; 2000 Apr; 54(7):1482-7. PubMed ID: 10751262 [TBL] [Abstract][Full Text] [Related]
42. The relationship between excitement symptom severity and extrastriatal dopamine D Joo YH; Kim JH; Son YD; Kim HK; Shin YJ; Lee SY; Kim JH Eur Arch Psychiatry Clin Neurosci; 2018 Sep; 268(6):529-540. PubMed ID: 28623450 [TBL] [Abstract][Full Text] [Related]
43. Synthesis and evaluation of dopamine D3 receptor antagonist 11C-GR218231 as PET tracer for P-glycoprotein. de Vries EF; Kortekaas R; van Waarde A; Dijkstra D; Elsinga PH; Vaalburg W J Nucl Med; 2005 Aug; 46(8):1384-92. PubMed ID: 16085598 [TBL] [Abstract][Full Text] [Related]
44. Fluorine-18-labelled NCQ 115, a selective dopamine D-2 receptor ligand. Preparation and positron emission tomography. Halldin C; Högberg T; Farde L Nucl Med Biol; 1994 May; 21(4):627-31. PubMed ID: 9234320 [TBL] [Abstract][Full Text] [Related]
45. Differentiation of extrastriatal dopamine D2 receptor density and affinity in the human brain using PET. Olsson H; Halldin C; Farde L Neuroimage; 2004 Jun; 22(2):794-803. PubMed ID: 15193608 [TBL] [Abstract][Full Text] [Related]
46. Decreased dopamine D2/D3-receptor binding in temporal lobe epilepsy: an [18F]fallypride PET study. Werhahn KJ; Landvogt C; Klimpe S; Buchholz HG; Yakushev I; Siessmeier T; Müller-Forell W; Piel M; Rösch F; Glaser M; Schreckenberger M; Bartenstein P Epilepsia; 2006 Aug; 47(8):1392-6. PubMed ID: 16922886 [TBL] [Abstract][Full Text] [Related]
48. Effect of amphetamine on [(18)F]fallypride in vivo binding to D(2) receptors in striatal and extrastriatal regions of the primate brain: Single bolus and bolus plus constant infusion studies. Slifstein M; Narendran R; Hwang DR; Sudo Y; Talbot PS; Huang Y; Laruelle M Synapse; 2004 Oct; 54(1):46-63. PubMed ID: 15300884 [TBL] [Abstract][Full Text] [Related]
50. Age-related dopamine D2/D3 receptor loss in extrastriatal regions of the human brain. Kaasinen V; Vilkman H; Hietala J; Någren K; Helenius H; Olsson H; Farde L; Rinne J Neurobiol Aging; 2000; 21(5):683-8. PubMed ID: 11016537 [TBL] [Abstract][Full Text] [Related]
51. In vivo imaging of dopamine receptors in a model of temporal lobe epilepsy. Yakushev IY; Dupont E; Buchholz HG; Tillmanns J; Debus F; Cumming P; Heimann A; Fellgiebel A; Luhmann HJ; Landvogt C; Werhahn KJ; Schreckenberger M; Potschka H; Bartenstein P Epilepsia; 2010 Mar; 51(3):415-22. PubMed ID: 19694792 [TBL] [Abstract][Full Text] [Related]
52. PET mapping of extrastriatal D2-like dopamine receptors in the human brain using an anatomic standardization technique and [11C]FLB 457. Okubo Y; Olsson H; Ito H; Lofti M; Suhara T; Halldin C; Farde L Neuroimage; 1999 Dec; 10(6):666-74. PubMed ID: 10600412 [TBL] [Abstract][Full Text] [Related]
53. In vivo quantification of regional dopamine-D3 receptor binding potential of (+)-PHNO: Studies in non-human primates and transgenic mice. Rabiner EA; Slifstein M; Nobrega J; Plisson C; Huiban M; Raymond R; Diwan M; Wilson AA; McCormick P; Gentile G; Gunn RN; Laruelle MA Synapse; 2009 Sep; 63(9):782-93. PubMed ID: 19489048 [TBL] [Abstract][Full Text] [Related]
54. Radiosynthesis and evaluation of [11C]-(+)-4-propyl-3,4,4a,5,6,10b-hexahydro-2H-naphtho[1,2-b][1,4]oxazin-9-ol as a potential radiotracer for in vivo imaging of the dopamine D2 high-affinity state with positron emission tomography. Wilson AA; McCormick P; Kapur S; Willeit M; Garcia A; Hussey D; Houle S; Seeman P; Ginovart N J Med Chem; 2005 Jun; 48(12):4153-60. PubMed ID: 15943487 [TBL] [Abstract][Full Text] [Related]
55. Quantitation of striatal and extrastriatal D-2 dopamine receptors using PET imaging of [(18)F]fallypride in nonhuman primates. Christian BT; Narayanan TK; Shi B; Mukherjee J Synapse; 2000 Oct; 38(1):71-9. PubMed ID: 10941142 [TBL] [Abstract][Full Text] [Related]
56. Comparison of two fluorine-18 labeled benzamide derivatives that bind reversibly to dopamine D2 receptors: in vitro binding studies and positron emission tomography. Mach RH; Nader MA; Ehrenkaufer RL; Line SW; Smith CR; Luedtke RR; Kung MP; Kung HF; Lyons D; Morton TE Synapse; 1996 Dec; 24(4):322-33. PubMed ID: 10638823 [TBL] [Abstract][Full Text] [Related]
57. Quantification of [11C]FLB 457 binding to extrastriatal dopamine receptors in the human brain. Olsson H; Halldin C; Swahn CG; Farde L J Cereb Blood Flow Metab; 1999 Oct; 19(10):1164-73. PubMed ID: 10532641 [TBL] [Abstract][Full Text] [Related]
58. In vitro pharmacological profile of YM-43611, a novel D2-like receptor antagonist with high affinity and selectivity for dopamine D3 and D4 receptors. Hidaka K; Tada S; Matsumoto M; Ohmori J; Tasaki Y; Nomura T; Usuda S; Yamaguchi T Br J Pharmacol; 1996 Apr; 117(8):1625-32. PubMed ID: 8732269 [TBL] [Abstract][Full Text] [Related]